adapalene vs ivermectin topical
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of adapalene and ivermectin topical. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Differin
Soolantra
No summary available.
Soolantra cream contains ivermectin and is used on the skin. It helps treat bumps and pimples caused by rosacea.
Information not available.
Soolantra cream treats the inflammatory bumps and pimples caused by rosacea. Rosacea is a common skin condition that causes redness and visible blood vessels in your face. It may also produce small, red, pus-filled bumps.
Information not available.
The exact way Soolantra works is not known. It is thought that ivermectin reduces inflammation. It may also kill certain mites that can contribute to rosacea.
- • Dry skin
- • Contact dermatitis (skin rash)
- • Burning feeling on the skin where you put the medicine
- • Skin irritation
- • Skin burning sensation
- • Skin irritation
- Dry Skin 44,990
- Skin Burning Sensation 41,633
- Acne 39,264
- Erythema 38,379
- Skin Irritation 26,225
No adverse event reports.
No specific warnings noted.
There are no contraindications (reasons not to use) listed for this medication.
No pregnancy information available.
It is not known if Soolantra cream can harm an unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if Soolantra passes into breast milk.
Also Compare, Nearby Drugs
Compare adapalene with
Compare ivermectin topical with
How to Read This adapalene vs ivermectin topical Comparison
adapalene is classified in the Retinoid (Topical) drug class, while ivermectin topical sits within the Topical Antiparasitic class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adapalene has 190,491 submissions while ivermectin topical has 0. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for adapalene or ivermectin topical.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.